EnanDIM - A novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy

Kerstin Kapp, Barbara Volz, Michael A. Curran, Detlef Oswald, Burghardt Wittig, Manuel Schmidt

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'EnanDIM - A novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences